Patients that are acquiring cyclosporine, tacrolimus or other agents to forestall graft-compared to-host disease article bone marrow transplant usually are not suitable for this demo Experimental: Dose expansion_sub-populace 2_higher dose of niraparib MTDs and/or prospect RP2Ds for elimusertib utilized in combination with niraparib at a greater fixed dose. Qualifying aberrations https://sandraw009iue2.jasperwiki.com/user